ES2659353T3 - Métodos y formulaciones nutricionales para aumentar la eficacia y reducir los efectos secundarios del tratamiento del cáncer - Google Patents
Métodos y formulaciones nutricionales para aumentar la eficacia y reducir los efectos secundarios del tratamiento del cáncer Download PDFInfo
- Publication number
- ES2659353T3 ES2659353T3 ES10825771.8T ES10825771T ES2659353T3 ES 2659353 T3 ES2659353 T3 ES 2659353T3 ES 10825771 T ES10825771 T ES 10825771T ES 2659353 T3 ES2659353 T3 ES 2659353T3
- Authority
- ES
- Spain
- Prior art keywords
- food
- component
- meals
- providing
- cancer patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/60—Comminuted or emulsified meat products, e.g. sausages; Reformed meat from comminuted meat product
- A23L13/65—Sausages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/20—Making of laminated, multi-layered, stuffed or hollow foodstuffs, e.g. by wrapping in preformed edible dough sheets or in edible food containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Business, Economics & Management (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tourism & Hospitality (AREA)
- Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Economics (AREA)
- Entrepreneurship & Innovation (AREA)
- Human Resources & Organizations (AREA)
- Marketing (AREA)
- Operations Research (AREA)
- Quality & Reliability (AREA)
- Strategic Management (AREA)
- General Business, Economics & Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25415409P | 2009-10-22 | 2009-10-22 | |
| US254154P | 2009-10-22 | ||
| PCT/US2010/053821 WO2011050302A2 (en) | 2009-10-22 | 2010-10-22 | Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2659353T3 true ES2659353T3 (es) | 2018-03-14 |
Family
ID=43900993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10825771.8T Active ES2659353T3 (es) | 2009-10-22 | 2010-10-22 | Métodos y formulaciones nutricionales para aumentar la eficacia y reducir los efectos secundarios del tratamiento del cáncer |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20110118528A1 (enExample) |
| EP (1) | EP2490684B1 (enExample) |
| JP (1) | JP2013508411A (enExample) |
| CN (1) | CN102753162A (enExample) |
| AU (2) | AU2010310515B2 (enExample) |
| BR (1) | BR112012009423A2 (enExample) |
| CA (1) | CA2779282C (enExample) |
| DK (1) | DK2490684T3 (enExample) |
| ES (1) | ES2659353T3 (enExample) |
| PL (1) | PL2490684T3 (enExample) |
| PT (1) | PT2490684T (enExample) |
| RU (1) | RU2549954C2 (enExample) |
| WO (1) | WO2011050302A2 (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2822178T3 (es) * | 2012-10-22 | 2021-04-29 | Univ Southern California | Formulaciones dietéticas que promueven la regeneración de tejidos/órganos |
| CN114236130A (zh) * | 2013-02-12 | 2022-03-25 | 南加利福尼亚大学 | 用于减轻年龄相关症状的膳食包装 |
| NZ715431A (en) | 2013-07-01 | 2022-02-25 | Univ Southern California | Fasting condition as dietary treatment of diabetes |
| CN106456631A (zh) * | 2014-03-06 | 2017-02-22 | 南加利福尼亚大学 | 利用短期饥饿方案结合激酶抑制剂来增强传统化学药物功效和可行性并逆转激酶在正常细胞和组织中的副作用 |
| US10172839B2 (en) | 2014-03-06 | 2019-01-08 | University Of Southern California | Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues |
| US10117872B2 (en) * | 2014-03-28 | 2018-11-06 | Università Degli Studi Di Genova | Tyrosine kinase inhibitors for use in a method of treating cancer in association with a reduced caloric intake |
| MX2016012896A (es) * | 2014-04-02 | 2017-05-12 | Univ Southern California | Autoinmunidad y tratamiento de la esclerosis multiple. |
| CA3108664A1 (en) * | 2015-04-16 | 2016-10-20 | University Of Southern California | Fasting mimicking diet (fmd) and glucose lowering drugs protect normal cells and generate cancer sensitizing conditions in response to standard and high glucose conditions induced by rapamycin and dexamethasone |
| CA2984891A1 (en) | 2015-05-06 | 2016-11-10 | University Of Southern California | Fasting mimicking and enhancing diet for treating hypertension and lipid disorders |
| AU2016328683A1 (en) * | 2015-09-21 | 2018-05-10 | Ifom Fondazione Istituto Firc Di Oncologia Molecolare | New therapeutic strategies against blood cancer |
| AU2017207370B2 (en) * | 2016-01-12 | 2021-09-23 | University Of Southern California | Use of long-term fasting mimicking as dietary treatment for multiple myeloma and other cancers |
| AU2017219732B2 (en) | 2016-02-15 | 2022-01-20 | University Of Southern California | Drug combinations and methods to stimulate embryonic-like regeneration to treat diabetes and other diseases |
| CN109069462A (zh) | 2016-02-23 | 2018-12-21 | 癌症研究科技有限公司 | 缺乏至少两种非必需氨基酸的膳食产品 |
| AU2017261723B2 (en) | 2016-05-11 | 2023-02-09 | University Of Southern California | Fasting mimicking diet (FMD) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases. |
| IT201700008499A1 (it) * | 2017-01-26 | 2018-07-26 | Univ Degli Studi Genova | Composizione dietetica per la prevenzione e/o il trattamento dell’iperplasia dell’endometrio |
| US11284640B2 (en) | 2017-02-14 | 2022-03-29 | University Of Southern California | Fasting mimicking diet |
| CN107951892A (zh) * | 2018-01-19 | 2018-04-24 | 丽水学院 | 锌原卟啉在制备增强人结直肠癌细胞对5-氟尿嘧啶化疗敏感性药物中的应用 |
| KR20200125966A (ko) | 2018-03-15 | 2020-11-05 | 유니버시티 오브 써던 캘리포니아 | 염증 및 ibd 병리의 역전을 촉진하는, 물만 섭취하는 금식이 아닌 금식 모방 식이요법 (fmd) |
| DE212018000421U1 (de) * | 2018-07-18 | 2021-03-01 | Andreas Michalsen | Auswirkungen einer kurzzeitigen Diät, die Fasten imitiert, auf die Lebensqualität und die Verträglichkeit einer Chemotherapie bei Patientinnen mit Krebs |
| AU2019376681B2 (en) | 2018-11-09 | 2025-07-24 | L-Nutra Inc. | Nutrition bar for intermittent fasting-mimicking |
| US12185747B2 (en) | 2019-04-30 | 2025-01-07 | University Of Southern California | Fasting-mimicking diet (FMD) as an intervention for Alzheimer's disease (AD) |
| JP6747702B1 (ja) * | 2019-05-10 | 2020-08-26 | 株式会社医療情報技術研究所 | 栄養処方管理システム |
| KR20220098682A (ko) * | 2019-05-14 | 2022-07-12 | 타임, 인크. | 암을 치료하기 위한 조성물 및 방법 |
| IT201900009954A1 (it) * | 2019-06-24 | 2020-12-24 | Fondazione Irccs Istituto Naz Dei Tumori | Preparazione alimentare a basso contenuto calorico per l’alimentazione di pazienti affetti da neoplasie |
| WO2021118324A1 (ko) * | 2019-12-13 | 2021-06-17 | 서울대학교산학협력단 | 암의 예방 또는 치료용 약학 조성물 |
| IT202000007153A1 (it) | 2020-04-03 | 2021-10-03 | Ifom Fondazione St Firc Di Oncologia Molecolare | Apporto calorico ridotto e immunoterapia per il trattamento del cancro |
| US10905698B1 (en) | 2020-05-14 | 2021-02-02 | Tyme, Inc. | Methods of treating SARS-COV-2 infections |
| JP2023530235A (ja) | 2020-06-03 | 2023-07-14 | フェス・セラピューティクス，インコーポレーテッド | 個別化された処置方法のための製剤 |
| CN116133653A (zh) | 2020-06-04 | 2023-05-16 | 菲思治疗公司 | 治疗癌症的个体化方法 |
| TW202227113A (zh) | 2020-12-01 | 2022-07-16 | 南加州州立大學 | 模擬禁食飲食提升急性淋巴母細胞白血病模型中的無癌存活 |
| US20240000125A1 (en) * | 2020-12-17 | 2024-01-04 | Fondazione Irccs Istituto Nazionale Dei Tumori | Diet preparation for the nutrition of cancer patients with a restricted calorie intake |
| EP4066823B1 (en) | 2021-03-30 | 2025-04-30 | IFOM - Istituto Fondazione di Oncologia Molecolare ETS | Reduced caloric intake and anticancer agents for the treatment of cancer |
| CN115590963A (zh) * | 2022-07-13 | 2023-01-13 | 复旦大学（Cn） | 酮体、酮体诱导剂和生酮组合物中的至少一种在治疗和/或预防血小板减少症药物中的应用 |
| EP4599826A1 (en) | 2024-02-06 | 2025-08-13 | IFOM - Istituto Fondazione di Oncologia Molecolare ETS | Leucine for use in the treatment of cancer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2074731C1 (ru) * | 1994-12-29 | 1997-03-10 | Игорь Александрович Бойко | Фитокомплекс, обладающий противоопухолевым действием, и способ лечения онкологических больных |
| RU2224510C2 (ru) * | 1997-03-17 | 2004-02-27 | Би Ти Джи Интернэшнл Лимитед | Терапевтические композиции |
| AU5319499A (en) * | 1999-07-22 | 2001-02-13 | Ivan L. Cameron | Fatty acids to minimize cancer therapy side effects |
| JP4625156B2 (ja) * | 2000-04-10 | 2011-02-02 | イーエヌ大塚製薬株式会社 | 癌化学療法に伴う副作用軽減剤 |
| WO2005117542A2 (en) * | 2004-05-10 | 2005-12-15 | Novacea, Inc. | Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments |
| AU2005296271A1 (en) * | 2004-10-15 | 2006-04-27 | University Of Tennessee Research Foundation | Methods for inducing apoptosis in adipocytes |
| US20070116802A1 (en) * | 2005-11-23 | 2007-05-24 | Carl Germano | High quality caloric composition |
| US20080038367A1 (en) * | 2006-08-11 | 2008-02-14 | Sal Saloum | Nutritional supplement compositions and methods of preparing |
| RU2354369C2 (ru) * | 2007-03-16 | 2009-05-10 | Михаил Владимирович Кутушов | Применение родамина 6ж в качестве лекарственного средства для лечения злокачественных новообразований и амилоидозов |
| ES2891733T3 (es) * | 2007-03-28 | 2022-01-31 | Univ Southern California | Inducción de la resistencia diferencial al estrés y usos de la misma |
| MX2010005768A (es) * | 2007-11-26 | 2010-06-11 | Nestec Sa | Composiciones y métodos para inhibir la activación del arnbc-dependiente de la proteina de la kinasa y la inhibición del crecimiento tumoral. |
-
2010
- 2010-10-22 CA CA2779282A patent/CA2779282C/en active Active
- 2010-10-22 WO PCT/US2010/053821 patent/WO2011050302A2/en not_active Ceased
- 2010-10-22 ES ES10825771.8T patent/ES2659353T3/es active Active
- 2010-10-22 RU RU2012118588/15A patent/RU2549954C2/ru active
- 2010-10-22 EP EP10825771.8A patent/EP2490684B1/en active Active
- 2010-10-22 US US12/910,508 patent/US20110118528A1/en not_active Abandoned
- 2010-10-22 CN CN2010800560747A patent/CN102753162A/zh active Pending
- 2010-10-22 PL PL10825771T patent/PL2490684T3/pl unknown
- 2010-10-22 JP JP2012535426A patent/JP2013508411A/ja active Pending
- 2010-10-22 PT PT108257718T patent/PT2490684T/pt unknown
- 2010-10-22 BR BR112012009423A patent/BR112012009423A2/pt not_active Application Discontinuation
- 2010-10-22 DK DK10825771.8T patent/DK2490684T3/en active
- 2010-10-22 AU AU2010310515A patent/AU2010310515B2/en active Active
-
2016
- 2016-03-11 AU AU2016201607A patent/AU2016201607B2/en active Active
-
2021
- 2021-03-17 US US17/204,419 patent/US20210209516A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20110118528A1 (en) | 2011-05-19 |
| CN102753162A (zh) | 2012-10-24 |
| PL2490684T3 (pl) | 2018-07-31 |
| EP2490684A2 (en) | 2012-08-29 |
| RU2549954C2 (ru) | 2015-05-10 |
| AU2016201607B2 (en) | 2017-11-30 |
| PT2490684T (pt) | 2018-04-02 |
| WO2011050302A2 (en) | 2011-04-28 |
| EP2490684B1 (en) | 2018-01-03 |
| BR112012009423A2 (pt) | 2017-06-13 |
| US20210209516A1 (en) | 2021-07-08 |
| CA2779282C (en) | 2017-12-05 |
| RU2012118588A (ru) | 2013-11-27 |
| AU2010310515A1 (en) | 2012-05-17 |
| AU2010310515B2 (en) | 2016-01-07 |
| CA2779282A1 (en) | 2011-04-28 |
| AU2016201607A1 (en) | 2016-03-31 |
| DK2490684T3 (en) | 2018-04-09 |
| EP2490684A4 (en) | 2016-05-04 |
| WO2011050302A3 (en) | 2011-08-25 |
| JP2013508411A (ja) | 2013-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2659353T3 (es) | Métodos y formulaciones nutricionales para aumentar la eficacia y reducir los efectos secundarios del tratamiento del cáncer | |
| Farahat et al. | Effect of dietary supplementation of grape seed extract on the growth performance, lipid profile, antioxidant status and immune response of broiler chickens | |
| ES2807781T3 (es) | Composición de dieta para usar en un método terapéutico para reducir los niveles de glucosa en sangre y/o de IGF-1 | |
| ES2954473T3 (es) | Aditivo para alimentación de ganado | |
| CO6351747A2 (es) | Composicion nutricional para promover desarrollo y crecimiento saludables | |
| JP2015510888A5 (enExample) | ||
| PH12012502279A1 (en) | Tube feed formulations and methods for using same | |
| ES2947500T3 (es) | Composiciones orales antiparasitarias | |
| BR112017009678A2 (pt) | composição optimizada de nutrientes de ácidos graxos e método de preparação da mesma | |
| Kale et al. | Role of antioxidants and nutrition in oxidative stress: a review | |
| RU2006130739A (ru) | Питательная композиция для улучшения состояния кожи и предотвращения кожных заболеваний | |
| Owens | Nutritional support to counteract muscle atrophy | |
| CL2023002451A1 (es) | Composiciones y métodos que usan una combinación de oleuropeína y vitamina b6 | |
| Sahin et al. | Role of the antioxidant defence system and transcription factors in preventing heat stress in poultry: a dietary approach | |
| EA202092105A1 (ru) | Фармацевтический состав или состав пищевой добавки на основе альфа-лактальбумина | |
| SG162836A1 (en) | Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases | |
| ES2716278T3 (es) | Productos para administración oral que comprenden extractos de granada Punica granatum, pensados para un animal de compañía, y aplicaciones de los mismos | |
| Alalwan | Nutraceuticals and their role in promoting musculoskeletal healthy aging. | |
| Sutili et al. | Clove Oil, eugenol effective anesthetics for silver catfish, other Brazilian species | |
| US10499664B2 (en) | Fish feed formulation of Hypericum perforatum, Rosamarinus officianalis or a mixture thereof | |
| Srikijkasemwat et al. | Oregano (Origanum vulgare L.) essential oil as a natural growth promoter in broiler chickens | |
| RU2013154562A (ru) | Способы и композиции для сохранения безжировой массы тела в процессе похудения | |
| JP2020503061A (ja) | 心血管性の効率に影響を与える栄養補助食品 | |
| RU2012156681A (ru) | Средство (варианты), фармацевтическая композиция и способ химиопрофилактики предрака и рака предстательной железы | |
| Messonnier | Nutritional Supplements for the Veterinary Practice: A Pocket Guide |